CoStar Data Shows Strong Prelet Activity Driving UK Lab Space Demand to a Record High
Bullish for CSGP in 1–3 months as strong UK lab-space data validates its analytics platform.
Signal detail
Source-backed analysis, the reasoning behind the signal, and its market context.
Bullish for CSGP in 1–3 months as strong UK lab-space data validates its analytics platform.
What happened and why it matters
CoStar reports record UK life-science space demand, led by GSK's Cambridge pre-let and a rebound in Cambridge activity. The data show high take-up, rising vacancies, and a shrinking development pipeline, with 1.4 million square feet due by year-end and more than 40% uncommitted. The findings reinforce CoStar's status as a leading CRE analytics provider.
The article is a data release rather than a direct earnings trigger; it supports CoStar's analytics narrative but lacks explicit revenue or margin implications.
GSK pre-let at Cambridge boosts UK life-science demand; Q3 take-up >1.2M sf.
Cambridge prelet 300k sf; Prologis 112.6k sf Phase 2 approved.
Q2 2026 UK lab vacancies at 14.3%; Golden Triangle vacancies >25%.
1.8M sf new lab space in two years; 1.4M sf due by year-end; >40% uncommitted.
Costar’s data shows ~118M monthly visitors in Q2 2026.
Industry News. The piece centers on CRE market data and demand drivers, aligning with CoStar's core analytics business.
More AI-analyzed coverage connected to this story